Collaborations

Jinwei has obtained license from Theravectys to commercially produce gene transfer vector incorporating the DNA flap sequence in China.
  • Technology and Know-how

    1. One of the leading therapeutic oncological platforms.
    2. Multiple patents and other IP under two existing. collaboration agreements. 
    3. A wide range of indications for pre-clinical and clinical developments.

  • Development, Manufacture and Commercialization

    1. The only company licensed to commercially produce gene transfer vector incorporating the DNA flap sequence in China.
    2. Established partnership with the Huashan Hospital to develop therapies for oncological diseases such as liver and prostate cancers as well as infectious diseases such as HBV and Tuberculosis.